Universal theranostic CRISPR/Cas13a RNA-editing system for glioma

Background: The CRISPR/Cas13a system offers the advantages of rapidity, precision, high sensitivity, and programmability as a molecular diagnostic tool for critical illnesses. One of the salient features of CRISPR/Cas13a-based bioassays is its ability to recognize and cleave the target RNA specifica...

Descripción completa

Detalles Bibliográficos
Autores principales: Wu, Ye, Wang, Yunfei, Zhou, Junhu, Wang, Jianhao, Zhan, Qi, Wang, Qixue, Yang, Eryan, Jin, Weili, Tong, Fei, Zhao, Jixing, Hong, Biao, Liu, Junrui, Kang, Chunsheng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Ivyspring International Publisher 2023
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10614676/
https://www.ncbi.nlm.nih.gov/pubmed/37908718
http://dx.doi.org/10.7150/thno.84429

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10614676/
https://www.ncbi.nlm.nih.gov/pubmed/37908718
http://dx.doi.org/10.7150/thno.84429

Ejemplares similares